Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel, Evan M. Bloch, William Clarke, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 191

Showing 26-50 of 191 citing articles:

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
Michael T. Ou, Brian J. Boyarsky, Teresa Po‐Yu Chiang, et al.
Transplantation (2021) Vol. 105, Iss. 9, pp. 2119-2123
Open Access | Times Cited: 61
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
Andrew M. Hallett, Ross S. Greenberg, Brian J. Boyarsky, et al.
The Journal of Heart and Lung Transplantation (2021) Vol. 40, Iss. 12, pp. 1579-1588
Open Access | Times Cited: 61
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Andrea Padoan, Francesco Bonfante, Chiara Cosma, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 8, pp. 1444-1452
Open Access | Times Cited: 59
Electrochemical Capillary-Flow Immunoassay for Detecting Anti-SARS-CoV-2 Nucleocapsid Protein Antibodies at the Point of Care
Isabelle C. Samper, Ana Sánchez, Wisarut Khamcharoen, et al.
ACS Sensors (2021) Vol. 6, Iss. 11, pp. 4067-4075
Open Access | Times Cited: 57
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Maggie Li, E. Beck, Oliver Laeyendecker, et al.
Blood Advances (2022) Vol. 6, Iss. 12, pp. 3678-3683
Open Access | Times Cited: 54
Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study
Caren Sourij, Norbert J. Tripolt, Faisal Aziz, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 849-858
Open Access | Times Cited: 53
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, et al.
Journal of General Virology (2023) Vol. 104, Iss. 5
Open Access | Times Cited: 30
Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic
Laura C. Steinhardt, Fehintola Ige, Nnaemeka C. Iriemenam, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 7
Open Access | Times Cited: 52
COVID-19 convalescent plasma
Aaron A.R. Tobian, Claudia S. Cohn, Beth H. Shaz
Blood (2021) Vol. 140, Iss. 3, pp. 196-207
Open Access | Times Cited: 47
SARS-CoV-2 seroprevalence in Germany
Daniela Gornyk, Manuela Harries, Stephan Glöckner, et al.
Deutsches Ärzteblatt international (2021)
Open Access | Times Cited: 44
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Isabel Montesinos, Hafid Dahma, Fleur Wolff, et al.
Journal of Clinical Virology (2021) Vol. 144, pp. 104988-104988
Open Access | Times Cited: 43
COVID‐19 convalescent plasma: Interim recommendations from the AABB
Claudia S. Cohn, Lise J Estcourt, Brenda J. Grossman, et al.
Transfusion (2021) Vol. 61, Iss. 4, pp. 1313-1323
Open Access | Times Cited: 41
The effectiveness of inactivated SARS‐CoV‐2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older
Murat Karameşe, Emin Ediz Tütüncü
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 173-177
Open Access | Times Cited: 40
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
Paul Duengelhoef, Johannes Hartl, Darius F. Rüther, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 3, pp. 319-329
Open Access | Times Cited: 35
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Muneyoshi Kimura, Victor H. Ferreira, Sagar Kothari, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 10, pp. 706.e1-706.e10
Open Access | Times Cited: 35
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
Marie Pouquet, Dorine Decarreaux, Laura Di Domenico, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
Tania S. Bonny, Eshan U. Patel, Xianming Zhu, et al.
Open Forum Infectious Diseases (2020) Vol. 8, Iss. 2
Open Access | Times Cited: 45
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
Christopher D. Heaney, Nora Pisanic, Pranay R. Randad, et al.
Journal of Clinical Virology (2021) Vol. 145, pp. 104997-104997
Open Access | Times Cited: 37
Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort
Mélanie Deschasaux, Bernard Srour, Laurent Bourhis, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 36
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker, Zin Naing, Alberto Ospina Stella, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 247-247
Open Access | Times Cited: 35
SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications
N. A. Toropov, Eleanor L. Osborne, Lovleen Tina Joshi, et al.
ACS Sensors (2021) Vol. 6, Iss. 8, pp. 2815-2837
Open Access | Times Cited: 35
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Amy B. Karger, James D. Brien, Jayne M. Christen, et al.
mSphere (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 23
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Nora Pisanic, Annukka A.R. Antar, Kate Kruczynski, et al.
Journal of Immunological Methods (2023) Vol. 514, pp. 113440-113440
Open Access | Times Cited: 13
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time
Grace Kenny, Sophie O’Reilly, N. Kelly, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study
Troy J. Kemp, Heidi Hempel, Yuanji Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 12

Scroll to top